Skip to main content
. 2021 Feb 12;9:621748. doi: 10.3389/fbioe.2021.621748

FIGURE 3.

FIGURE 3

Therapeutic properties of MSC spheroids in vivo. Upon infusion in vivo, MSC spheroid “medicinal signaling” activities are exerted by the paracrine secretion of modulatory mediators that possess immunomodulatory and trophic (i.e., angiogenic, anti-fibrotic, anti-apoptotic, and mitogenic) actions. MSC spheroids have been safely and effectively applied in various preclinical animal models for the treatment of skin wounds, myocardial infarction, vascular injury/ischemia, liver injury, kidney injury, bone and osteochondral defects, and knee synovitis.